U.S. flag

An official website of the United States government

NM_000249.4(MLH1):c.207+5G>C AND Lynch syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 25, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000491027.3

Allele description [Variation Report for NM_000249.4(MLH1):c.207+5G>C]

NM_000249.4(MLH1):c.207+5G>C

Gene:
MLH1:mutL homolog 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000249.4(MLH1):c.207+5G>C
HGVS:
  • NC_000003.12:g.36996714G>C
  • NG_007109.2:g.8365G>C
  • NG_008418.1:g.1591C>G
  • NM_000249.4:c.207+5G>CMANE SELECT
  • NM_001167617.3:c.-83+5G>C
  • NM_001167618.3:c.-517+5G>C
  • NM_001167619.3:c.-425+5G>C
  • NM_001258271.2:c.207+5G>C
  • NM_001258273.2:c.-517+3051G>C
  • NM_001258274.3:c.-662+5G>C
  • NM_001354615.2:c.-420+5G>C
  • NM_001354616.2:c.-425+5G>C
  • NM_001354617.2:c.-517+5G>C
  • NM_001354618.2:c.-517+5G>C
  • NM_001354619.2:c.-517+5G>C
  • NM_001354620.2:c.-83+5G>C
  • NM_001354621.2:c.-610+5G>C
  • NM_001354622.2:c.-723+5G>C
  • NM_001354623.2:c.-723+2824G>C
  • NM_001354624.2:c.-620+5G>C
  • NM_001354625.2:c.-523+5G>C
  • NM_001354626.2:c.-620+5G>C
  • NM_001354627.2:c.-620+5G>C
  • NM_001354628.2:c.207+5G>C
  • NM_001354629.2:c.207+5G>C
  • NM_001354630.2:c.207+5G>C
  • LRG_216t1:c.207+5G>C
  • LRG_216:g.8365G>C
  • NC_000003.11:g.37038205G>C
  • NM_000249.3:c.207+5G>C
Links:
dbSNP: rs587781518
NCBI 1000 Genomes Browser:
rs587781518
Molecular consequence:
  • NM_000249.4:c.207+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001167617.3:c.-83+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001167618.3:c.-517+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001167619.3:c.-425+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001258271.2:c.207+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001258273.2:c.-517+3051G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001258274.3:c.-662+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354615.2:c.-420+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354616.2:c.-425+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354617.2:c.-517+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354618.2:c.-517+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354619.2:c.-517+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354620.2:c.-83+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354621.2:c.-610+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354622.2:c.-723+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354623.2:c.-723+2824G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354624.2:c.-620+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354625.2:c.-523+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354626.2:c.-620+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354627.2:c.-620+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354628.2:c.207+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354629.2:c.207+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354630.2:c.207+5G>C - intron variant - [Sequence Ontology: SO:0001627]
Observations:
1

Condition(s)

Name:
Lynch syndrome
Identifiers:
MONDO: MONDO:0005835; MedGen: C4552100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000579490University of Washington Department of Laboratory Medicine, University of Washington
criteria provided, single submitter

(Shirts et al. (Genet Med 2016))
Pathogenic
(Mar 25, 2016)
germline, not applicableclinical testing, in vitro

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1yesclinical testing
not providednot applicablenot applicablenot providednot providednot providednot providednot providedin vitro

Citations

PubMed

Improving performance of multigene panels for genomic analysis of cancer predisposition.

Shirts BH, Casadei S, Jacobson AL, Lee MK, Gulsuner S, Bennett RL, Miller M, Hall SA, Hampel H, Hisama FM, Naylor LV, Goetsch C, Leppig K, Tait JF, Scroggins SM, Turner EH, Livingston R, Salipante SJ, King MC, Walsh T, Pritchard CC.

Genet Med. 2016 Oct;18(10):974-81. doi: 10.1038/gim.2015.212. Epub 2016 Feb 4.

PubMed [citation]
PMID:
26845104

Details of each submission

From University of Washington Department of Laboratory Medicine, University of Washington, SCV000579490.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providedyesclinical testing PubMed (1)
2not providednot providednot providednot providedin vitro PubMed (1)

Description

RNA evidence indicating exon 2 skipping and familial co-segregation analysis indicated evidence for cosegregation of this variant with colon cancers that have loss of MLH1 on IHC (likelihood ratio 25.28, LOD: 1.4). Taken together this is sufficient evidence for variant pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided
2not applicablenot applicablenot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024